66 related articles for article (PubMed ID: 7834820)
21. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
[TBL] [Abstract][Full Text] [Related]
22. Taxol enhances but does not induce interleukin-1 beta and tumor necrosis factor-alpha production.
Allen JN; Moore SA; Wewers MD
J Lab Clin Med; 1993 Oct; 122(4):374-81. PubMed ID: 7901310
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic reduction in tumor necrosis factor activity of pulmonary alveolar macrophages.
Leeper-Woodford SK; Fisher BJ; Sugerman HJ; Fowler AA
Am J Respir Cell Mol Biol; 1993 Feb; 8(2):169-75. PubMed ID: 8093999
[TBL] [Abstract][Full Text] [Related]
24. Effect of surfactant protein A (SP-A) on the production of cytokines by human pulmonary macrophages.
Arias-Diaz J; Garcia-Verdugo I; Casals C; Sanchez-Rico N; Vara E; Balibrea JL
Shock; 2000 Sep; 14(3):300-6. PubMed ID: 11028547
[TBL] [Abstract][Full Text] [Related]
25. [Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline].
Tong ZH; Dai HP; Chen BM; Wang C; Guzman J; Costabel U
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jul; 26(7):415-8. PubMed ID: 12921647
[TBL] [Abstract][Full Text] [Related]
26. In vitro expression and inhibition of procoagulant activity produced by bovine alveolar macrophages and peripheral blood cells.
Rashid J; Weiss DJ; Maheswaran SK; Murtaugh MP
Vet Res Commun; 1996; 20(6):519-31. PubMed ID: 8950833
[TBL] [Abstract][Full Text] [Related]
27. [Effects of pentoxifylline on leukocyte in the lungs of dog with fat tissue extract-induced respiratory distress syndrome].
Xu JC; Guo XJ; Mao BL
Zhonghua Nei Ke Za Zhi; 1994 Apr; 33(4):248-50. PubMed ID: 7956564
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone.
Tong Z; Dai H; Chen B; Abdoh Z; Guzman J; Costabel U
Chest; 2003 Oct; 124(4):1526-32. PubMed ID: 14555589
[TBL] [Abstract][Full Text] [Related]
29. Serum components enhance bacterial lipopolysaccharide-induced tissue factor expression and tumor necrosis factor-alpha secretion by bovine alveolar macrophages in vitro.
Yang Z; Khemlani LS; Dean DF; Carter CD; Slauson DO; Bochsler PN
J Leukoc Biol; 1994 Apr; 55(4):483-8. PubMed ID: 7511678
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of endogenous TNF formation by pentoxifylline.
Zabel P; Schade FU; Schlaak M
Immunobiology; 1993 Apr; 187(3-5):447-63. PubMed ID: 8330908
[TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharide and a phorbol ester stimulate secretion of tumor necrosis factor-alpha from alveolar macrophages through action on overlapping subsets of cells.
Taylor MJ; Hehnke K; Clark CL
J Leukoc Biol; 1993 Nov; 54(5):384-8. PubMed ID: 8228617
[TBL] [Abstract][Full Text] [Related]
32. Production of TNF alpha by LPS-stimulated murine, rat and human blood and its pharmacological modulation.
Foster SJ; McCormick LM; Ntolosi BA; Campbell D
Agents Actions; 1993; 38 Spec No():C77-9. PubMed ID: 8317328
[TBL] [Abstract][Full Text] [Related]
33. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis.
Lauterbach R; Zembala M
Eur J Pediatr; 1996 May; 155(5):404-9. PubMed ID: 8741040
[TBL] [Abstract][Full Text] [Related]
34. Effect of human recombinant tumour necrosis factor-alpha and pentoxifylline on the ultrastructure of type II alveolar epithelial cells in pregnant and non-pregnant rabbits.
Sulkowska M
J Comp Pathol; 1997 Oct; 117(3):227-36. PubMed ID: 9447483
[TBL] [Abstract][Full Text] [Related]
35. [Pentoxifylline inhibits secretion of O2- and TNF-alpha by alveolar macrophages in patients with sarcoidosis].
Körber M; Kamp S; Kothe H; Braun J; Dalhoff K
Immun Infekt; 1995 Jun; 23(3):107-10. PubMed ID: 7615305
[TBL] [Abstract][Full Text] [Related]
36. Long-chain predominant lipid emulsions inhibit in vitro macrophage tumor necrosis factor production.
Vazquez WD; Arya G; Garcia VF
JPEN J Parenter Enteral Nutr; 1994; 18(1):35-9. PubMed ID: 8164300
[TBL] [Abstract][Full Text] [Related]
37. Immunological aspects of the effect of pentoxifylline (Trental) (a brief review).
Balázs C; Kiss E
Acta Microbiol Immunol Hung; 1994; 41(2):121-6. PubMed ID: 7804717
[TBL] [Abstract][Full Text] [Related]
38. Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality.
Noel P; Nelson S; Bokulic R; Bagby G; Lippton H; Lipscomb G; Summer W
Life Sci; 1990; 47(12):1023-9. PubMed ID: 2233123
[TBL] [Abstract][Full Text] [Related]
39. Pentoxiphylline reduces nitric oxide production among patients with HIV infection.
Wanchu A; Khullar M; Bhatnagar A; Sud A; Bambery P; Singh S
Immunol Lett; 2000 Oct; 74(2):121-5. PubMed ID: 10996387
[TBL] [Abstract][Full Text] [Related]
40. Effect of anticancer drugs on the release of tumour necrosis factor in vitro.
Hasan SI; Ahmed K; Turk JL
Cancer Immunol Immunother; 1990; 30(6):363-6. PubMed ID: 2302726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
